NCT02136667

Brief Summary

In order to assess circulating biomarkers of cardiovascular risk, we will conduct a 10-year follow-up study comparing 32 exposed (women with a history of pregnancy complicated by preeclampsia) and 32 unexposed (women with a history of uncomplicated pregnancy). Participants will be recruited from a well-characterised cohort, previously assembled during their pregnancies, at the Department of Obstetrics at Randers Regional Hospital in 2001-2004. Blood and urine samples, collected during their pregnancies, are stored in a biobank, thus rendering the possibility of longitudinal assessment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2014

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 1, 2014

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 13, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

January 6, 2015

Status Verified

May 1, 2014

Enrollment Period

8 months

First QC Date

May 1, 2014

Last Update Submit

January 5, 2015

Conditions

Keywords

PreeclampsiaCardiovascular disease (CVD) risk

Outcome Measures

Primary Outcomes (1)

  • Circulating biomarkers of cardiovascular disease 10 years postpartum.

    10 years postpartum

Secondary Outcomes (2)

  • Markers of arteriosclerosis and atherosclerosis

    10 years postpartum

  • Circulating biomarkers of cardiovascular disease at baseline pregnancy.

    During pregnancy

Study Arms (2)

Exposed

Women with a history of preeclampsia 10 years ago

Unexposed

Women with a history of uncomplicated pregnancy 10 years ago

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Participants will be recruited from a well-characterised cohort, previously assembled at the Department of Obstetrics at Randers Regional Hospital in 2001-2005.

You may qualify if:

  • Participation in previous study 2001-2005.

You may not qualify if:

  • Current pregnancy or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Randers Regional Hospital

Randers, Randers NØ, 8930, Denmark

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Blood serum Blood plasma Urine

MeSH Terms

Conditions

Pre-EclampsiaCardiovascular Diseases

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Ulla B Knudsen, Professor

    Department of Obstetrics and Gynaecology, Aarhus University Hospital

    STUDY CHAIR
  • Martin Christensen, MD

    Clinical Research Unit, Randers Regional Hospital

    PRINCIPAL INVESTIGATOR
  • Camilla S Kronborg, MD, PhD

    Department of Oncology, Aarhus University Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2014

First Posted

May 13, 2014

Study Start

April 1, 2014

Primary Completion

December 1, 2014

Study Completion

December 1, 2015

Last Updated

January 6, 2015

Record last verified: 2014-05

Locations